He is a dynamic and results-driven techno-commercial leader with a rich 15-year background in shaping Strategy and Business Development across the Pharmaceuticals, Biosimilars, Biologics, and Vaccines landscape. Recognized for successfully spearheading the development of innovative drug delivery platforms, navigating them through clinical stages, and achieving successful commercialization. His journey across diverse organizations has provided a wealth of experience, fostering a deep understanding of drug delivery systems across various categories. His expertise extends to project management, technology transfer, and the intricacies of business development and marketing strategies, with a particular focus on Pharmaceuticals, Biosimilars, and Novel Assets. He brings to the table a comprehensive grasp of competitive intelligence, regulatory science, and the nuanced realm of current regulatory policies and Intellectual Property Rights and Law (IPR). Key Skills & Specialties: - Biosimilars, Biologics, Vaccines - Business Development, Strategic Partnerships & Licensing - Competitive Intelligence, 505(b)(2) - Novel & Proprietary products, ANDAs - Regulatory Affairs, Patents Law Passionate about driving innovation and delivering impactful results, he thrives on navigating the complex intersections of science, strategy, and business to contribute meaningfully to the evolving landscape of healthcare.